Arkolith/Insider Trading/ARTL/Form 4

Gorgas Gregory D.

Pres, CEO, CFO, Treas & Sec, DirectorARTELO BIOSCIENCES, INC. (ARTL) · full profile →Form 4 · filed Mar 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2024Disposed to issuer(D)5K——0
Feb 28, 2024Disposed to issuer(D)56K——0
Feb 28, 2024Disposed to issuer(D)38K——0
Feb 28, 2024Disposed to issuer(D)90K——0
Feb 28, 2024Grant(A)85K——85K
Feb 28, 2024Grant(A)5K——5K
Feb 28, 2024Grant(A)56K——56K
Feb 28, 2024Grant(A)38K——38K
Feb 28, 2024Grant(A)90K——90K
Feb 28, 2024Disposed to issuer(D)85K——0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640334-24-000332) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ARTELO BIOSCIENCES, INC.

Build

Ask your agent about ARTL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001640334-24-000332"
Ask your agent
Use Arkolith to summarize insider buying and selling at ARTELO BIOSCIENCES, INC.
over the last 90 days and cite the filings.